STADA IRBESARTAN HCT 150/12.5 irbesartan/hydrochlorothiazide 150 mg/12.5 mg tablet blister Australia - English - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 150/12.5 irbesartan/hydrochlorothiazide 150 mg/12.5 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; povidone; microcrystalline cellulose; magnesium stearate; hydrogenated castor oil; maize starch; lactose monohydrate - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Aurorix New Zealand - English - Medsafe (Medicines Safety Authority)

aurorix

viatris limited - moclobemide 150mg - film coated tablet - 150 mg - active: moclobemide 150mg excipient: ethylcellulose hypromellose iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone purified talc sodium starch glycolate titanium dioxide - latest regulatory activity

TOPAMAX 50 TABLET 50 mg Singapore - English - HSA (Health Sciences Authority)

topamax 50 tablet 50 mg

johnson & johnson international (singapore) pte ltd - topiramate - tablet, film coated - 50 mg - topiramate 50 mg

AVSARTAN HCT 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

avsartan hct 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: povidone; hypromellose; colloidal anhydrous silica; mannitol; polysorbate 80; sodium starch glycollate type b; magnesium stearate; titanium dioxide; iron oxide yellow; iron oxide red; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AVSARTAN irbesartan 150 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

avsartan irbesartan 150 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; macrogol 6000; microcrystalline cellulose; sodium starch glycollate type b; hypromellose; magnesium stearate; polysorbate 80 - indicated for the treatment of hypertension.,indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (equal to or greater than 30mg per 24 hours) or urinary protein in excess of 900mg per 24 hours.

BLOOMS THE CHEMIST IRBESARTAN HCTZ 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

blooms the chemist irbesartan hctz 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.